GL1X · GenesisL1 explorer

MolNFT v1 · #135857 · protein

Inactive S1A/N269D-cppvdq mutant in complex with the pyoverdine precursor pvdiq reveals a specific binding pocket for the D-tyr of this substrate

5UBK · Acyl-homoserine lactone acylase pvdq: “Inactive S1A/N269D-cppvdq mutant in complex with the pyoverdine precursor pvdiq reveals a specific binding…”. X-ray diffraction, 1 ligand (83M), 6 pockets (best druggability 0.72). MolNFT v1…

PDB
5UBK
Type
protein
Length
709 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Acyl-homoserine lactone acylase pvdq
EC
3.5.1.97
UniProt
Q9I194
Ligands
83M
Pockets
6 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcyl-homoserine lactone acylase pvdq (EC 3.5.1.97)protein70934% helix, 25% strandQ9I194

Ligands and binding sites

  • 83M · N-[(1R)-1-{(6S)-6-[(2-amino-2-oxoethyl)carbamoyl]-1,4,5,6-tetrahydropyrimidin-2-yl}-2-(4-hydroxyphenyl)ethyl]-N~2~-tetradecanoyl-L-glutamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17560.720.789683M
21960.550.7925empty
31880.430.7331empty
41380.420.7520empty
5510.360.8018empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 5UBK · Inactive S1A/N269D-cpPvdQ mutant in complex with the pyoverdine precursor PVDIq reveals a… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9I194 · AlphaFold monomer V2.0 prediction for acyl-homoserine lactone acylase pvdq (Q9I194) · a predicted model of the same protein · chain A against A, TM-score 0.77

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.